AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
Capecitabine in Ghana
6 products registered with FDA Ghana — 4 active, 2 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| CAPETERO TABLETS | UNKNOWN-2d37dfd7 | — | active | 1 Mar 2030 |
| CAPETERO TABLETS | UNKNOWN-467e74c6 | — | active | 1 Mar 2030 |
| CAPEMAX TABLETS (Each tablet contains Capecitabine 500mg) | UNKNOWN-b0d883dc | — | active | 14 Feb 2027 |
| CAPEMAX TABLETS (Each tablet contains Capecitabine 500mg) | UNKNOWN-1eb79e06 | — | active | 14 Feb 2027 |
| XELODA TABLETS ( Each tablet contains Capecitabine 500mg) | UNKNOWN-6420e07f | F HOFFMAN-LA ROECHE LIMITED GRENZACHESTRASSE 124 CH-4070 BASEL SWITZERLAND | expired | 1 Aug 2026 |
| XELODA TABLETS ( Each tablet contains Capecitabine 500mg) | UNKNOWN-d69891ee | F HOFFMAN-LA ROECHE LIMITED GRENZACHESTRASSE 124 CH-4070 BASEL SWITZERLAND | expired | 1 Aug 2026 |
Capecitabine — FDA Ghana Registration Details
FDA Ghana (Ghana) has 6 registered products containing Capecitabine, of which 4 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track Capecitabine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.